Wednesday, July, 24, 2019 04:44:12

HOOKIPA attains HIV collaboration and license agreement with Gilead

The deal will grant Gilead rights over HOOKIPA’s immunization technologies for developing immunotherapies against HIV and HBV. HOOKIPA Pharma Inc., a clinical-stage company developing novel immunotherapies targeting infectious diseases and cancers, has recently acquired its first research milestone through a collaboration and license agreement with …

GeoVax & Enesi team up to develop vaccines administered by ImplaVax®

The biotechnology company GeoVax Labs, Inc. has reportedly announced to have joined hands with the pharmaceutical firm Enesi Pharma to develop needle-free solid-dose vaccine formulations by using its unique Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform along with Enesi’s ImplaVax® device and formulation technology. …

Myriad Genetics announces the publication of Vectra(R) clinical study

The outcome of the Vectra(R) clinical studies were published in the journal Rheumatology. The adjusted Vectra(R) test is significantly more effective than conventional methods in predicting radiographic progression in individuals suffering from Rheumatoid Arthritis. Myriad Genetics, Inc. (Myriad), a leading American molecular diagnostic firm, has …

Sun Pharma arm gets relief in patent infringement case from U.S. court

DUSA Pharmaceuticals, a wholly-owned Sun Pharma subsidiary, had filed a patent infringement lawsuit against Biofrontera for using its proprietary trade secrets. The lawsuit claimed trade secret misappropriation as well as patent infringement of the firm’s photodynamic therapy patents. Sun Pharmaceutical Industries Ltd. (Sun Pharma), an …